RhumbLine Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.4M | Buy |
369,575
+12,580
| +4% | +$800K | 0.02% | 625 |
|
|
2025
Q4 | $22.7M | Sell |
356,995
-28,818
| -7% | -$1.79M | 0.02% | 658 |
|
|
2025
Q3 | $21.2M | Sell |
385,813
-4,127
| -1% | -$170K | 0.02% | 695 |
|
|
2025
Q2 | $12.9M | Buy |
389,940
+16,085
| +4% | +$559K | 0.01% | 945 |
|
|
2025
Q1 | $15M | Sell |
373,855
-10,028
| -3% | -$461K | 0.01% | 842 |
|
|
2024
Q4 | $18.1M | Buy |
383,883
+5,207
| +1% | +$270K | 0.02% | 753 |
|
|
2024
Q3 | $20M | Sell |
378,676
-581
| -0.2% | -$32.4K | 0.02% | 712 |
|
|
2024
Q2 | $20.5M | Buy |
379,257
+72,618
| +24% | +$4.38M | 0.02% | 653 |
|
|
2024
Q1 | $21.5M | Buy |
306,639
+24,797
| +9% | +$1.92M | 0.02% | 669 |
|
|
2023
Q4 | $23.5M | Buy |
281,842
+6,973
| +3% | +$253K | 0.02% | 586 |
|
|
2023
Q3 | $8.1M | Buy |
274,869
+3,005
| +1% | +$100K | 0.01% | 1090 |
|
|
2023
Q2 | $8.87M | Buy |
271,864
+12,766
| +5% | +$472K | 0.01% | 1072 |
|
|
2023
Q1 | $9.12M | Buy |
259,098
+11,640
| +5% | +$475K | 0.01% | 1000 |
|
|
2022
Q4 | $11.3M | Buy |
247,458
+7,486
| +3% | +$322K | 0.02% | 867 |
|
|
2022
Q3 | $11.6M | Buy |
239,972
+22,124
| +10% | +$1.06M | 0.02% | 815 |
|
|
2022
Q2 | $8.56M | Buy |
217,848
+15,775
| +8% | +$635K | 0.01% | 977 |
|
|
2022
Q1 | $7.44M | Buy |
202,073
+14,552
| +8% | +$517K | 0.01% | 1092 |
|
|
2021
Q4 | $8.55M | Buy |
187,521
+525
| +0.3% | +$20.3K | 0.01% | 1070 |
|
|
2021
Q3 | $6.68M | Sell |
186,996
-8,605
| -4% | -$253K | 0.01% | 1172 |
|
|
2021
Q2 | $3.87M | Sell |
195,601
-7,616
| -4% | -$179K | 0.01% | 1575 |
|
|
2021
Q1 | $4.73M | Buy |
203,217
+4,538
| +2% | +$96.9K | 0.01% | 1431 |
|
|
2020
Q4 | $4.13M | Buy |
198,679
+12,175
| +7% | +$223K | 0.01% | 1466 |
|
|
2020
Q3 | $4.04M | Buy |
186,504
+12,185
| +7% | +$285K | 0.01% | 1292 |
|
|
2020
Q2 | $4.11M | Sell |
174,319
-6,314
| -3% | -$118K | 0.01% | 1320 |
|
|
2020
Q1 | $2.13M | Buy |
180,633
+3,406
| +2% | +$43.5K | ﹤0.01% | 1511 |
|
|
2019
Q4 | $1.88M | Buy |
177,227
+11,225
| +7% | +$115K | ﹤0.01% | 1824 |
|
|
2019
Q3 | $1.89M | Buy |
166,002
+5,294
| +3% | +$66.5K | ﹤0.01% | 1773 |
|
|
2019
Q2 | $1.81M | Buy |
160,708
+13,651
| +9% | +$132K | ﹤0.01% | 1799 |
|
|
2019
Q1 | $1.19M | Sell |
147,057
-977
| -0.7% | -$7.18K | ﹤0.01% | 1958 |
|
|
2018
Q4 | $936K | Buy |
148,034
+24,169
| +20% | +$177K | ﹤0.01% | 2044 |
|
|
2018
Q3 | $1.22M | Buy |
123,865
+4,035
| +3% | +$32.4K | ﹤0.01% | 1912 |
|
|
2018
Q2 | $995K | Buy |
119,830
+9,918
| +9% | +$82.5K | ﹤0.01% | 2014 |
|
|
2018
Q1 | $791K | Buy |
109,912
+4,392
| +4% | +$37.7K | ﹤0.01% | 2040 |
|
|
2017
Q4 | $860K | Buy |
105,520
+17,464
| +20% | +$198K | ﹤0.01% | 2012 |
|
|
2017
Q3 | $1.28M | Buy |
88,056
+5,470
| +7% | +$74.7K | ﹤0.01% | 1859 |
|
|
2017
Q2 | $999K | Buy |
82,586
+43,456
| +111% | +$604K | ﹤0.01% | 1954 |
|
|
2017
Q1 | $503K | Buy |
39,130
+1,133
| +3% | +$13.2K | ﹤0.01% | 2239 |
|
|
2016
Q4 | $462K | Buy |
37,997
+3,162
| +9% | +$33.6K | ﹤0.01% | 2270 |
|
|
2016
Q3 | $320K | Sell |
34,835
-5,860
| -14% | -$61.2K | ﹤0.01% | 2452 |
|
|
2016
Q2 | $386K | Sell |
40,695
-2,501
| -6% | -$20.5K | ﹤0.01% | 2373 |
|
|
2016
Q1 | $305K | Buy |
43,196
+2,580
| +6% | +$18.8K | ﹤0.01% | 2518 |
|
|
2015
Q4 | $425K | Buy |
40,616
+720
| +2% | +$7.06K | ﹤0.01% | 2346 |
|
|
2015
Q3 | $267K | Buy |
39,896
+1,831
| +5% | +$12.5K | ﹤0.01% | 2625 |
|
|
2015
Q2 | $256K | Sell |
38,065
-8,565
| -18% | -$56.2K | ﹤0.01% | 2757 |
|
|
2015
Q1 | $316K | Buy |
46,630
+1,300
| +3% | +$9.71K | ﹤0.01% | 2580 |
|
|
2014
Q4 | $363K | Buy |
45,330
+4,100
| +10% | +$17.6K | ﹤0.01% | 2474 |
|
|
2014
Q3 | $145K | Hold |
41,230
| – | – | ﹤0.01% | 2863 |
|
|
2014
Q2 | $197K | Buy |
41,230
+26,003
| +171% | +$159K | ﹤0.01% | 2846 |
|
|
2014
Q1 | $145K | Buy |
15,227
+3,850
| +34% | +$34.8K | ﹤0.01% | 2863 |
|
|
2013
Q4 | $74K | Buy |
11,377
+1,100
| +11% | +$7.23K | ﹤0.01% | 2981 |
|
|
2013
Q3 | $78K | Sell |
10,277
-223
| -2% | -$2.39K | ﹤0.01% | 2953 |
|
|
2013
Q2 | $121K | Buy |
+10,500
| New | +$82.7K | ﹤0.01% | 3196 |
|
Other funds holding CYTK
VPM
VCM
ACA
